An insight on topically applied formulations for management of various skin disorders

References

• Benson HAE, Watkinson AC. Transdermal and topical drug delivery: principles and practice. Hoboken, New Jersey: Wiley; 2012.
   Google Scholar
• Aulton ME. Aulton’s pharmaceutics:the design and manufacture of medicines. 3rd ed. London: Harcourt Publ. Limited. 2007. p. 175–177.
   Google Scholar
• Mann ER. Review: skin and the immune system. J Clin Exp Dermatol Res. 2014;4:1–16.
   Google Scholar
• Romanovsky AA. Skin temperature: its role in thermoregulation. Acta Physiol. 2014;210(3):498–507.
   PubMed Web of Science ®Google Scholar
• Brown MB, Martin GP, Jones SA, et al. Drug delivery dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 2006;13(3):175–187.
   PubMed Web of Science ®Google Scholar
• Mayersohn M. Modern pharmaceutics. 4th ed. Revised and Expanded. Boca Raton: CRC Press; 2002.
   Google Scholar
• Abourehab MAS, Ahmed OAA, Balata GF, et al. Self-assembled biodegradable polymeric micelles to improve dapoxetine delivery across the blood–brain barrier. Int J Nanomed. 2018;13:3679–3687.
   PubMed Web of Science ®Google Scholar
• Dong J, Tao L, Abourehab MAS, et al. Design and development of novel hyaluronate-modified nanoparticles for combo-delivery of curcumin and alendronate: fabrication, characterization, and cellular and molecular evidences of enhanced bone regeneration. Int J Biol Macromol. 2018;116:1268–1281.
   PubMed Web of Science ®Google Scholar
• Zhuo F, Abourehab MAS, Hussain Z. Hyaluronic acid decorated tacrolimus-loaded nanoparticles: efficient approach to maximize dermal targeting and anti-dermatitis efficacy. Carbohydr Polym. 2018;197:478–489.
   PubMed Web of Science ®Google Scholar
• Anderson BD, Higuchi WI, Raykar PV. Herterogeneity effects of permeability-partition coefficient relationships in human stratum corneum. Pharm Res. 1988;5(9):566–573.
   PubMed Web of Science ®Google Scholar
• Abdelhaleem Ali AM, Khames A, Alrobaian MM, et al. Glucosamine-paracetamol spray-dried solid dispersions with maximized intrinsic dissolution rate, bioavailability and decreased levels of in vivo toxic metabolites. Drug Des Devel Ther. 2018;12:3071–3084.
   PubMed Web of Science ®Google Scholar
• Abourehab MAS. Hyaluronic acid modified risedronate and teriparatide Co-loaded nanocarriers for improved osteogenic differentiation of osteoblasts for the treatment of osteoporosis. Curr Pharm Des. 2019;25(27):2975–2988.
   PubMed Web of Science ®Google Scholar
• Bashir M, Ahmad J, Asif M, et al. Nanoemulgel, an innovative carrier for diflunisal topical delivery with profound anti-Inflammatory effect: in vitro and in vivo evaluation. Int J Nanomed. 2021;16:1457–1472.
   PubMed Web of Science ®Google Scholar
• Marwah H, Garg T, Goyal AK, et al. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 2016;23(2):564–578.
   PubMed Web of Science ®Google Scholar
• Madheswaran T, Baskaran R, Yoo BK, et al. In vitro and in vivo skin distribution of 5α-reductase inhibitors loaded into liquid crystalline nanoparticles. J Pharm Sci. 2017;106(11):3385–3394.
   PubMed Web of Science ®Google Scholar
• Feldmann RJ, Maibach HI. Regional variation in percutaneous penetration of 14C cortisol in man. J Invest Dermatol. 1967;48(2):181–183.
   PubMed Web of Science ®Google Scholar
• Kaur H, Kesharwani P. Advanced nanomedicine approaches applied for treatment of skin carcinoma. J Control Release. 2021;337:589–611.
   PubMed Web of Science ®Google Scholar
• Nielsen JB, Benfeldt E, Holmgaard R. Penetration through the skin barrier. Curr Probl Dermatol. 2016;49:103–111.
   PubMedGoogle Scholar
• Choudhury H, Gorain B, Pandey M, et al. Recent update on nanoemulgel as topical drug delivery system. J Pharm Sci. 2017;106(7):1736–1751.
   PubMed Web of Science ®Google Scholar
• Walters KA. Dermatological and transdermal formulations. Boca Raton: CRC Press; 2002.
   Google Scholar
• Md S, Haque S, Madheswaran T, et al. Lipid based nanocarriers system for topical delivery of photosensitizers. Drug Discov Today. 2017;22(8):1274–1283.
   PubMed Web of Science ®Google Scholar
• Tripathi PK, Gorain B, Choudhury H, et al. Dendrimer entrapped microsponge gel of dithranol for effective topical treatment. Heliyon. 2019;5(3):e01343.
   PubMed Web of Science ®Google Scholar
• Wiechers JW. The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm Weekbl Sci. 1989;11(6):185–198.
   PubMedGoogle Scholar
• Behl CR, Flynn GL, Kurihara T, et al. Hydration and percutaneous absorption: I. Influence of hydration on alkanol permeation through hairless mouse skin. J Invest Dermatol. 1980;75(4):346–352.
   PubMed Web of Science ®Google Scholar
• Garg V, Nirmal J, Riadi Y, et al. Amelioration of endotoxin-induced uveitis in rabbit by topical administration of tacrolimus proglycosome nano-vesicles. J Pharm Sci. 2021;110(2):871–875.
   PubMed Web of Science ®Google Scholar
• Guy RH, Hadgraft J. Physicochemical aspects of percutaneous penetration and its enhancement. Pharm Res. 1988;5:753–758. [Mismatch
   PubMed Web of Science ®Google Scholar
• Srivastava S, Mahor A, Singh G, et al. Formulation development, in vitro and in vivo evaluation of topical hydrogel formulation of econazole nitrate-loaded β-cyclodextrin nanosponges. J Pharm Sci. 2021;110(11):3702–3714.
   PubMed Web of Science ®Google Scholar
• Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244–253.
   PubMed Web of Science ®Google Scholar
• Jafar G, Abdassah M, Rusdiana T, et al. Development and characterization of Precirol ATO 88 base in nanostructured lipid carriers (NLC) formulation with the probe sonication method. Int J Appl Pharm. 2021;13:43–46.
   Google Scholar
• Shah R, Soni T, Shah U, et al. Formulation development and characterization of lumefantrine nanosuspension for enhanced antimalarial activity. J Biomater Sci Polym Ed. 2021;32(7):833–857.
   PubMed Web of Science ®Google Scholar
• Gorain B, Choudhury H, Patro Sisinthy S, et al. Polymeric micelle-based drug delivery systems for tuberculosis treatment. In: Kesharwani P, editor. Nanotechnology based approaches for tuberculosis treatment. Cambridge (MA): Academic Press; 2020. p. 175–191.
   Google Scholar
• Thakare R, Kaul G, Shukla M, et al. Repurposing nonantibiotic drugs as antibacterials. In: Kesharwani P, Chopra S, Dasgupta A, editors. Drug discovery targeting drug-resistant bacteria. Cambridge (MA): Academic Press; 2020. p. 105–138.
   Google Scholar
• De Campos AM, Sánchez A, Alonso MJ. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm. 2001;224(1–2):159–168.
   PubMed Web of Science ®Google Scholar
• Singh A, Handa M, Ruwali M, et al. Nanocarrier mediated autophagy: an emerging trend for cancer therapy. Process Biochem. 2021;109:198–206.
   Web of Science ®Google Scholar
• Singh AR, Desu PK, Nakkala RK, et al. Nanotechnology-based approaches applied to nutraceuticals. Drug Deliv Transl Res. 2021;12:485–499.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Md S, Alhakamy NA, et al. QbD enabled azacitidine loaded liposomal nanoformulation and its in vitro evaluation. Polymers. 2021;13(2):250.
   PubMed Web of Science ®Google Scholar
• Kumar Singh P, Gorain B, Choudhury H, et al. Macrophage targeted amphotericin B nanodelivery systems against visceral leishmaniasis. Mater Sci Eng B Solid-State Mater Adv Technol. 2020;258:114571.
   Google Scholar
• Rathore P, Mahor A, Jain S, et al. Formulation development: in vitro and in vivo evaluation of chitosan engineered nanoparticles for ocular delivery of insulin. RSC Adv. 2020;10(71):43629–43639.
   PubMed Web of Science ®Google Scholar
• Singh S, Numan A, Somaily HH, et al. Nano-enabled strategies to combat methicillin-resistant Staphylococcus aureus. Mater Sci Eng C Mater Biol Appl. 2021;129:112384.
   PubMed Web of Science ®Google Scholar
• Sheihet L, Chandra P, Batheja P, et al. Tyrosine-derived nanospheres for enhanced topical skin penetration. Int J Pharm. 2008;350(1–2):312–319.
   PubMedGoogle Scholar
• Kathe K, Kathpalia H. Film forming systems for topical and transdermal drug delivery. Asian J Pharm Sci. 2017;12(6):487–497.
   PubMed Web of Science ®Google Scholar
• Bhowmik D, Gopinath H, Pragati Kumar B, et al. Recent advances in novel topical drug delivery system. Pharma Innov 2012;1(9):12–31.
   Google Scholar
• Dayan N. Pathways for skin penetration. Cosmet Toilet. 2005;120:67–76.
   Google Scholar
• Schaefer H, Redelmeier TE. Skin penetration. In: Textbook of contact dermatitis. 2001. p. 167–178.
   Google Scholar
• Devaux S, Castela A, Archier E, et al. Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26:61–67.
   PubMed Web of Science ®Google Scholar
• Tan X, Feldman SR, Chang J, et al. Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert Opin Drug Deliv. 2012;9(10):1263–1271.
   PubMed Web of Science ®Google Scholar
• Korting HC, Schäfer-Korting M. Carriers in the topical treatment of skin disease. Handb Exp Pharmacol. 2010;197:435–468.
   PubMedGoogle Scholar
• Pople PV, Singh KK. Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. AAPS PharmSciTech. 2006;7(4):91–E69.
   PubMed Web of Science ®Google Scholar
• Baroli B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J Pharm Sci. 2010;99(1):21–50.
   PubMed Web of Science ®Google Scholar
• Cevc G, Vierl U. Nanotechnology and the transdermal route. A state of the art review and critical appraisal. J Control Release. 2010;141(3):277–299.
   PubMed Web of Science ®Google Scholar
• Şenyiǧit T, Sonvico F, Barbieri S, et al. Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. J Control Release. 2010;142(3):368–373.
   PubMed Web of Science ®Google Scholar
• Luengo J, Weiss B, Schneider M, et al. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol. 2006;19(4):190–197.
   PubMed Web of Science ®Google Scholar
• Rangari AT. Polymeric nanoparticles based topical drug delivery: an overview. Asian J Biomed Pharm Sci. 2015;5(47):5–12.
   Google Scholar
• Dodane V, Amin Khan M, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm. 1999;182(1):21–32.
   PubMed Web of Science ®Google Scholar
• Valenta C, Auner BG. The use of polymers for dermal and transdermal delivery. Eur J Pharm Biopharm. 2004;58(2):279–289.
   PubMed Web of Science ®Google Scholar
• Tan Q, Liu W, Guo C, et al. Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery. Int J Nanomed. 2011;6:1621.
   PubMed Web of Science ®Google Scholar
• Choksi AN, Poonawalla T, Wilkerson MG. Nanoparticles: a closer look at their dermal effects. J Drugs Dermatol. 2010;9:475–481.
   PubMed Web of Science ®Google Scholar
• Mu L, Seow PH. Application of TPGS in polymeric nanoparticulate drug delivery system. Colloids Surf B Biointerfaces. 2006;47(1):90–97.
   PubMed Web of Science ®Google Scholar
• Gamer AO, Leibold E, Van Ravenzwaay B. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol In Vitro. 2006;20(3):301–307.
   PubMed Web of Science ®Google Scholar
• Cross SE, Innes B, Roberts MS, et al. Human skin penetration of sunscreen nanoparticles: in-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol Physiol. 2007;20(3):148–154.
   PubMed Web of Science ®Google Scholar
• Liu J, Hu W, Chen H, et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 2007;328(2):191–195.
   PubMed Web of Science ®Google Scholar
• Reifenrath WG, Hawkins GS, Kurtz MS. Percutaneous penetration and skin retention of topically applied compounds: an in vitro‐in vivo study. J Pharm Sci. 1991;80(6):526–532.
   PubMed Web of Science ®Google Scholar
• Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm. 2010;385(1–2):113–142.
   PubMed Web of Science ®Google Scholar
• Thananukul K, Kaewsaneha C, Opaprakasit P, et al. Smart gating porous particles as new carriers for drug delivery. Adv Drug Deliv Rev. 2021;174:425–446.
   PubMed Web of Science ®Google Scholar
• Siqueira NM, Contri RV, Paese K, et al. Innovative sunscreen formulation based on benzophenone-3-loaded chitosan-coated polymeric nanocapsules. Skin Pharmacol Physiol. 2011;24(3):166–174.
   PubMed Web of Science ®Google Scholar
• Rinaudo M. Chitin and chitosan: properties and applications. Prog Polym Sci. 2006;31(7):603–632.
   Web of Science ®Google Scholar
• Khalid A, Ahmed N, Chaudhery I, et al. Polysaccharide chemistry in drug delivery, endocrinology, and vaccines, chem. Chemistry. 2021;27(33):8437–8451.
   PubMed Web of Science ®Google Scholar
• Jensen LB, Petersson K, Nielsen HM. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin. Eur J Pharm Biopharm. 2011;79(1):68–75.
   PubMed Web of Science ®Google Scholar
• Iafisco M, Ruiz ME, Montoto SS, et al. Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects. Front Mol Biosci. 2020;7:587997.
   PubMed Web of Science ®Google Scholar
• Shrotriya S, Ranpise N, Satpute P, et al. Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis. Artif Cells Nanomed Biotechnol. 2018;46(7):1471–1482.
   PubMed Web of Science ®Google Scholar
• Jenning V, Schäfer-Korting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release. 2000;66(2–3):115–126.
   PubMed Web of Science ®Google Scholar
• Jain AK, Jain A, Garg NK, et al. Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment. Colloids Surf B Biointerfaces. 2014;121:222–229.
   PubMed Web of Science ®Google Scholar
• Souto EB, Wissing SA, Barbosa CM, et al. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 2004;278(1):71–77.
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56(5):603–618.
   PubMed Web of Science ®Google Scholar
• Chen H, Chang X, Du D, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release. 2006;110(2):296–306.
   PubMed Web of Science ®Google Scholar
• Sanna V, Gavini E, Cossu M, et al. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. J Pharm Pharmacol. 2007;59(8):1057–1064.
   PubMed Web of Science ®Google Scholar
• Schubert MA, Müller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles – evaluation of the method and process parameters. Eur J Pharm Biopharm. 2003;55(1):125–131.
   PubMed Web of Science ®Google Scholar
• Puglia C, Filosa R, Peduto A, et al. Evaluation of alternative strategies to optimize ketorolac transdermal delivery. AAPS PharmSciTech. 2006;7(3):64.
   PubMed Web of Science ®Google Scholar
• Jain S, Jain S, Khare P, et al. Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Deliv. 2010;17(6):443–451.
   PubMed Web of Science ®Google Scholar
• Bitar A, Zafar N, Valour JP, et al. Elaboration of sponge-like particles for textile functionalization and skin penetration. Colloid Polym Sci. 2015;293(10):2967–2977.
   Web of Science ®Google Scholar
• Chauhan I, Yasir M, Verma M, et al. Nanostructured lipid carriers: a groundbreaking approach for transdermal drug delivery. Adv Pharm Bull. 2020;10(2):150–165.
   PubMed Web of Science ®Google Scholar
• Rapalli VK, Kaul V, Waghule T, et al. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery: optimization, scale-up, in-vitro characterization and assessment of ex-vivo skin deposition. Eur J Pharm Sci. 2020;152:105438.
   PubMed Web of Science ®Google Scholar
• Ahmad Nasrollahi S, Koohestani F, Naeimifar A, et al. Preparation and evaluation of adapalene nanostructured lipid carriers for targeted drug delivery in acne. Dermatol Ther. 2021;34:1–10.
   Web of Science ®Google Scholar
• Ricci M, Puglia C, Bonina F, et al. Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. J Pharm Sci. 2005;94(5):1149–1159.
   PubMed Web of Science ®Google Scholar
• Jenning V, Gysler A, Schäfer-Korting M, et al. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm. 2000;49(3):211–218.
   PubMed Web of Science ®Google Scholar
• Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1–2):170–184.
   PubMed Web of Science ®Google Scholar
• Han F, Yin R, Che X, et al. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation. Int J Pharm. 2012;439(1–2):349–357.
   PubMed Web of Science ®Google Scholar
• Sala M, Diab R, Elaissari A, et al. Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications. Int J Pharm. 2018;535(1–2):1–17.
   PubMed Web of Science ®Google Scholar
• Nafisi S, Maibach HI. Chapter 3 – Skin penetration of nanoparticles. In: Shegokar R., Souto I, editors. Emerging nanotechnologies in immunology. Micro nano technologies. Boston: Elsevier; 2018. p. 47–88.
   Google Scholar
• Sala M, Elaissari A, Fessi H. Advances in psoriasis physiopathology and treatments: up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS). J Control Release. 2016;239:182–202.
   PubMed Web of Science ®Google Scholar
• Pavoni L, Perinelli DR, Bonacucina G, et al. An overview of micro-and nanoemulsions as vehicles for essential oils: formulation, preparation and stability. Nanomaterials. 2020;10(1):135.
   Web of Science ®Google Scholar
• Souto EB, Cano A, Martins-Gomes C, et al. Microemulsions and nanoemulsions in skin drug delivery. Bioengineering. 2022;9(4):158.
   PubMedGoogle Scholar
• Patel HK, Barot BS, Parejiya PB, et al. Topical delivery of clobetasol propionate loaded microemulsion based gel for effective treatment of vitiligo: ex vivo permeation and skin irritation studies. Colloids Surf B Biointerfaces. 2013;102:86–94.
   PubMed Web of Science ®Google Scholar
• Bin Huang Y, Lin YH, Lu TM, et al. Transdermal delivery of capsaicin derivative-sodium nonivamide acetate using microemulsions as vehicles. Int J Pharm. 2008;349(1–2):206–211.
   PubMedGoogle Scholar
• Thakur K, Sharma G, Singh B, et al. Cationic-bilayered nanoemulsion of fusidic acid: an investigation on eradication of methicillin-resistant Staphylococcus aureus 33591 infection in burn wound. Nanomedicine. 2018;13(8):825–847.
   PubMed Web of Science ®Google Scholar
• Allahou L, Madani S, Seifalian A. Investigating the application of liposomes as drug delivery systems for the diagnosis and treatment of cancer. Int J Biomater. 2021;2021:3041969.
   PubMed Web of Science ®Google Scholar
• Reljic R, Kumar A, Fraziano M, et al. The multirole of liposomes in therapy and prevention of infectious diseases. Front Immunol. 2018;9:155.
   PubMed Web of Science ®Google Scholar
• Pierre MBR, Dos Santos Miranda Costa I. Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch Dermatol Res. 2011;303(9):607–621.
   PubMed Web of Science ®Google Scholar
• Fresno Contreras MJ, Jiménez Soriano MM, Ramírez Diéguez A. In vitro percutaneous absorption of all-trans retinoic acid applied in free form or encapsulated in stratum corneum lipid liposomes. Int J Pharm. 2005;297(1–2):134–145.
   PubMedGoogle Scholar
• Osborne DW. Diethylene glycol monoethyl ether: an emerging solvent in topical dermatology products. J Cosmet Dermatol. 2011;10(4):324–329.
   PubMed Web of Science ®Google Scholar
• Godwin DA, Kim NH, Felton LA. Influence of Transcutol® CG on the skin accumulation and transdermal permeation of ultraviolet absorbers. Eur J Pharm Biopharm. 2002;53(1):23–27.
   PubMed Web of Science ®Google Scholar
• Frederiksen K, Guy RH, Petersson K. Formulation considerations in the design of topical, polymeric film-forming systems for sustained drug delivery to the skin. Eur J Pharm Biopharm. 2015;91:9–15.
   PubMed Web of Science ®Google Scholar
• Kathe K, Kathpalia H. Film forming systems for topical and transdermal drug delivery. Asian J Pharm Sci. 2017;12(6):487–497.
   PubMed Web of Science ®Google Scholar
• Vij NN, Saudagar RB. Formulation, development and evaluation of film-forming gel for prolonged dermal delivery of terbinafine. Int J Pharm Sci Res. 2014;5:537–554.
   Google Scholar
• Vintiloiu A, Leroux J-C. Organogels and their use in drug delivery – a review. J Control Release. 2008;125(3):179–192.
   PubMed Web of Science ®Google Scholar
• Murdan S. Organogels in drug delivery. Expert Opin Drug Deliv. 2005;2(3):489–505.
   PubMedGoogle Scholar
• Prow TW, Grice JE, Lin LL, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev. 2011;63(6):470–491.
   PubMed Web of Science ®Google Scholar
• McLafferty E, Hendry C, Farley A. The integumentary system: anatomy, physiology and function of skin. Nurs Stand. 2012;27(3):35–42.
   Google Scholar
• Prausnitz MR, Elias PM, Franz TJ, et al. Skin barrier and transdermal drug delivery. In: Medical therapy. 2012. p. 2065–2074.
   Google Scholar
• Tortora GJ, Derrickson B. Principles of anatomy & physiology. 14th ed. 2014.
   Google Scholar
• Kolarsick PAJ, Kolarsick MA, Goodwin C. Anatomy and physiology of the skin. J Dermatol Nurses Assoc. 2011;3:203–213.
   Google Scholar
• McGrath JA, Eady RAJ, Pope FM. Anatomy and organization of human skin. In: Rook’s textbook of dermatology. 2004. p. 45–128.
   Google Scholar
• Freinkel RK, Woodley DT. Introduction. In: The biology of the skin. New York: Parthenon Publication Group; 2001.
   Google Scholar
• Prieto-Granada CN, Lobo AZC, Mihm MC. Skin infections. In: Diagnostic pathology of infectious disease. Philadelphia, PA: Elsevier; 2018. p. 542–647.
   Google Scholar
• Chen Y-L, Kuan W-H, Liu C-L. Comparative study of the composition of sweat from eccrine and apocrine sweat glands during exercise and in heat. Int J Environ Res Public Health. 2020;17(10):3377.
   Web of Science ®Google Scholar
• Degitz K, Placzek M, Borelli C, et al. Pathophysiology of acne. J Dtsch Dermatol Ges. 2007;5(4):316–323.
   PubMedGoogle Scholar
• McDonnell JK, Tomecki KJ. Rosacea: an update. Cleve Clin J Med. 2000;67(8):587–590.
   PubMed Web of Science ®Google Scholar
• Georgala S, Katoulis AC, Kylafis GD, et al. Increased density of demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea. J Eur Acad Dermatol Venerol. 2001;15(5):441–444.
   PubMed Web of Science ®Google Scholar
• Jansen T, Plewig G. Rosacea: classification and treatment. J R Soc Med. 1997;90(3):144–150.
   PubMed Web of Science ®Google Scholar
• Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327–341.
   PubMed Web of Science ®Google Scholar
• Guarrera M, Parodi A, Cipriani C, et al. Flushing in rosacea: a possible mechanism. Arch Dermatol Res. 1982;272(3-4):311–316.
   PubMed Web of Science ®Google Scholar
• Griffiths C, Barker J. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263–271.
   PubMed Web of Science ®Google Scholar
• Psoriasis symptoms, treatment, causes, pictures & diet. (2022). https://www.webmd.com/skin-problems-and-treatments/psoriasis/understanding-psoriasis-basics
   Google Scholar
• Przybilla B, Eberlein-König B, Ruëff F. Practical management of atopic eczema. Lancet. 1994;343(8909):1342–1346.
   PubMed Web of Science ®Google Scholar
• Peng W, Novak N. Pathogenesis of atopic dermatitis. Clin Exp Allergy. 2015;45(3):566–574.
   PubMed Web of Science ®Google Scholar
• Atopic dermatitis (eczema)-topic overview. (n.d.). https://www.aad.org/public/diseases/eczema/types/atopic-dermatitis.
   Google Scholar
• Pereira LB. Impetigo – review. An Bras Dermatol. 2014;89(2):293–299.
   PubMed Web of Science ®Google Scholar
• Leyden JL. Tinea pedis pathophysiology and treatment. J Am Acad Dermatol. 1994;31(3 Pt 2):S31–S33.
   PubMed Web of Science ®Google Scholar
• Ezzedine K, Eleftheriadou V, Whitton M, et al. Vitiligo. Lancet. 2015;386(9988):74–84.
   PubMed Web of Science ®Google Scholar
• Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res. 2014;306(2):103–124.
   PubMed Web of Science ®Google Scholar
• Chien AL, Qi J, Rainer B, et al. Treatment of acne in pregnancy. J Am Board Fam Med. 2016;29(2):254–262.
   PubMed Web of Science ®Google Scholar
• Thiboutot D. The role of follicular hyperkeratinization in acne. J Dermatol Treat. 2000;11(2):5–8.
   Google Scholar
• Li VCY, Chowdhury MMU. Dermatological pharmacology: topical agents. Medicine. 2017;45(6):359–362.
   Google Scholar
• Maria A, Stanescu A, Simionescu AA, et al. Oral vitamin D therapy in patients with psoriasis. Nutrients. 2021;13(1):163.
   Web of Science ®Google Scholar
• Tanghetti E, Lebwohl M, Stein Gold L. Tazarotene revisited: safety and efficacy in plaque psoriasis and its emerging role in treatment strategy. J Drugs Dermatol. 2018;17(12):1280–1287.
   Web of Science ®Google Scholar
• García-Pérez ME, Kasangana PB, Stevanovic T. Bioactive polyphenols for diabetes and inflammation in psoriasis disease. Stud Nat Prod Chem. 2017;52:231–268.
   Google Scholar
• Generali JA, Cada DJ. Off-label drug uses oxymetazoline (topical): rosacea. Hosp Pharm. 2013;48(7):558–559.
   PubMedGoogle Scholar
• Sahoo A, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: a comprehensive review. Indian Dermatol Online J. 2016;7(2):77–86.
   PubMedGoogle Scholar
• Chang K-T, Lin HY-H, Kuo C-H, et al. Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes. J Microbiol Immunol Infect. 2016;49(3):409–416.
   PubMedGoogle Scholar
• Zane LT, Chanda S, Jarnagin K, et al. Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies. Immunotherapy. 2016;8(8):853–866.
   PubMed Web of Science ®Google Scholar
• Fleckman P. Management of the ichthyoses. Skin Ther Lett. 2003;8(6):3–7.
   PubMedGoogle Scholar